0
ARTICLE |

TREATMENT OF MONILIASIS WITH NYSTATIN

Edwin T. Wright, M.D.; James H. Graham, M.D.; Thomas H. Sternberg, M.D.
JAMA. 1957;163(2):92-94. doi:10.1001/jama.1957.02970370006002.
Text Size: A A A
Published online

• Nystatin, which has antibiotic effects in vitro against certain pathogenic fungi, was used in the treatment of 42 patients with oral, 17 with vaginal, and 63 with cutaneous forms of moniliasis. The antibiotic was applied topically in various ways; the vaginal suppositories, for example, contained 10,000 to 100,000 units of nystatin. The lesions of thrush and perlèche ordinarily disappeared within two or three days, although sometimes two or three weeks were required for a cure. The results were considered excellent in 53 of the 122 patients, good in 64, and fair in 5. There were no instances of either primary irritation or sensitization. In 52 of the patients the fungus remained demonstrable after the lesions had healed, yet relapses were infrequent. The patients in whom results were described as only fair either had severe systemic illnesses or were receiving prolonged steroid or antibiotic therapy. Solutions worked better than other dosage forms in intertriginous areas. An aqueous 2% procaine hydrochloride and 0.25% polysorbate 80 solution containing 100,000 units of nystatin and 2.5 mg. of hydrocortisone per cubic centimeter caused faster healing than did the same solution without the hydrocortisone.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs